Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department

As of March 30(th), 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise. Other than supportive care, there are no SARS-CoV-2 specific treatments available for patients discharged from the emergency department (ED) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Cortlyn, Noble, Jeanne, Coralic, Zlatan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2020
Materias:
Endemic Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234712/
https://www.ncbi.nlm.nih.gov/pubmed/32302280
http://dx.doi.org/10.5811/westjem.2020.3.47328
_version_ 1783535828198227968
author Brown, Cortlyn
Noble, Jeanne
Coralic, Zlatan
author_facet Brown, Cortlyn
Noble, Jeanne
Coralic, Zlatan
author_sort Brown, Cortlyn
collection PubMed
description As of March 30(th), 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise. Other than supportive care, there are no SARS-CoV-2 specific treatments available for patients discharged from the emergency department (ED) or those admitted to the hospital. In addition, there are no vaccines available to protect our at-risk healthcare workers. The National Institutes of Health is conducting a Phase 1 clinical trial to evaluate for a potential vaccine and the recipients have started to receive the investigational vaccine.2 We present a brief overview of the potential prophylactic and treatment agents under investigation, some which could be initiated in the ED if proven effective.
format Online
Article
Text
id pubmed-7234712
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Department of Emergency Medicine, University of California, Irvine School of Medicine
record_format MEDLINE/PubMed
spelling pubmed-72347122020-05-21 Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department Brown, Cortlyn Noble, Jeanne Coralic, Zlatan West J Emerg Med Endemic Infections As of March 30(th), 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise. Other than supportive care, there are no SARS-CoV-2 specific treatments available for patients discharged from the emergency department (ED) or those admitted to the hospital. In addition, there are no vaccines available to protect our at-risk healthcare workers. The National Institutes of Health is conducting a Phase 1 clinical trial to evaluate for a potential vaccine and the recipients have started to receive the investigational vaccine.2 We present a brief overview of the potential prophylactic and treatment agents under investigation, some which could be initiated in the ED if proven effective. Department of Emergency Medicine, University of California, Irvine School of Medicine 2020-05 2020-03-31 /pmc/articles/PMC7234712/ /pubmed/32302280 http://dx.doi.org/10.5811/westjem.2020.3.47328 Text en Copyright: © 2020 Brown et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Endemic Infections
Brown, Cortlyn
Noble, Jeanne
Coralic, Zlatan
Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
title Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
title_full Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
title_fullStr Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
title_full_unstemmed Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
title_short Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
title_sort brief summary of potential sars-cov-2 prophylactic and treatment drugs in the emergency department
topic Endemic Infections
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234712/
https://www.ncbi.nlm.nih.gov/pubmed/32302280
http://dx.doi.org/10.5811/westjem.2020.3.47328
work_keys_str_mv AT browncortlyn briefsummaryofpotentialsarscov2prophylacticandtreatmentdrugsintheemergencydepartment
AT noblejeanne briefsummaryofpotentialsarscov2prophylacticandtreatmentdrugsintheemergencydepartment
AT coraliczlatan briefsummaryofpotentialsarscov2prophylacticandtreatmentdrugsintheemergencydepartment

Ejemplares similares